Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria
Authors:
- Giuseppe PetraliaGPGiuseppe Petralia
- Matteo FerroMFMatteo Ferro
- Carmen Austrália Paredes Marcondes RibasCRCarmen Austrália Paredes Marcondes Ribas
- Serena DettiSDSerena Detti
- Barbara Alicja Jereczek-FossaBJBarbara Alicja Jereczek-Fossa
- Elena TagliabueETElena Tagliabue
- Deliu Victor MateiDMDeliu Victor Matei
- Ioan ComanICIoan Coman
- Ottavio De CobelliOCOttavio De Cobelli
- 6 April 2016
- journal article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 96 (4) , 459-469
Abstract
Objective: To evaluate the prognostic role of multiparametric-MRI (mp-MRI) in patients with clinically localized prostate cancer (PCa) eligible for active surveillance (AS) according to Prostate Cancer Research International: Active Surveillance (PRIAS) criteria. Patients and Methods: We analyzed prospectively 73 patients with PCa and PRIAS criteria for low-risk disease. All patients fitted criteria for AS but optioned surgery treatment. The mp-MRI was performed to define the likelihood of malignancy according to the Prostate Imaging Reporting and Data System (PIRADS) score (1-5). Patients were divided in 2 groups: non-visible cancer lesion on MRI (PIRADS 2-3) and visible cancer (PIRADS 4-5). Preoperative clinical data (age, body mass index, prostate specific antigen (PSA) level, positive core biopsy, PSA density (PSAD)) and definitive pathological findings (staging, upgrading, unfavorable disease) were compared between groups. PIRADS score was correlated with pathological data to evaluate the prognostic role of mp-MRI; and preoperative variables and definitive pathology (upgrading, upstaging and unfavorable disease) were also assessed. Results: PSAD (p = 0.04) and pathological stage (p = 0.03) were significantly associated with the presence of visible disease. Visible disease was significantly associated with upstaging (p = 0.03). Correlation between PIRADS 5 and unfavorable disease was statistically significant (p = 0.02). The mp-MRI had adequate sensibility in detecting upstaging (92%), intermediate for upgrading (76%) and unfavorable disease (76%). Negative predictive value was higher for upstaging than for upgrading or unfavorable disease (96 vs. 68% and 64%). Multivariate logistic regression revealed that PIRADS 5 was a significant predictor of upstaging (p = 0.05, OR 16.12) and unfavorable disease (p = 0.01, OR 6.53). Conclusion: A visible lesion on mp-MRI strongly predicts significant PCa in patients eligible for AS according to PRIAS criteria, based on upstaging and unfavorable disease. We believe that mp-MRI is an important tool and should be added to clinical selection criteria for AS.Keywords
This publication has 33 references indexed in Scilit:
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS StudyEuropean Urology, 2013
- Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillanceUrologic Oncology: Seminars and Original Investigations, 2012
- Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancerBJU International, 2011
- Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancerProstate Cancer and Prostatic Diseases, 2011
- Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy schemeBJU International, 2010
- Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ studyBJU International, 2010
- Active surveillance for the management of prostate cancer in a contemporary cohortCancer, 2008
- The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysisBJU International, 2007
- Localization of Prostate Cancer Using 3T MRIJournal of Computer Assisted Tomography, 2006
- ENDORECTAL MAGNETIC RESONANCE IMAGING AS A PREDICTOR OF BIOCHEMICAL OUTCOME AFTER RADICAL PROSTATECTOMY IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2000